Tachyarrhythmia

Cardiovascular
1
Pipeline Programs
3
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Biotronik
BiotronikGermany - Berlin
5 programs
1
Implantable cardioverter-defibrillatorPhase 41 trial
BIOMONITOR III and BIOMONITOR IIImN/A1 trial
BioMonitor 2N/A1 trial
CorSky ICD or CRT-DN/A1 trial
ProMRI ICD/CRT-D Post Approval StudyN/A1 trial
Active Trials
NCT04025710Completed167Est. Apr 2022
NCT02565238Completed92Est. Feb 2017
NCT07360158Not Yet Recruiting151Est. May 2028
+2 more trials
Rhythm Pharmaceuticals
3 programs
Activation of preventive and therapeutic algorithms for treatment of AFN/A1 trial
DefibrillationN/A1 trial
Full Automaticity and Remote Follow-upN/A1 trial
Active Trials
NCT00170274Completed156Est. Oct 2014
NCT04863664Completed998Est. Nov 2025
NCT01526629Completed354Est. Mar 2015
Eko Devices
Eko DevicesCA - Emeryville
1 program
Eko Duo electronic stethoscopeN/A1 trial
Active Trials
NCT06382207Recruiting100Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
BiotronikImplantable cardioverter-defibrillator
BiotronikCorSky ICD or CRT-D
Eko DevicesEko Duo electronic stethoscope
Rhythm PharmaceuticalsDefibrillation
BiotronikBIOMONITOR III and BIOMONITOR IIIm
BiotronikProMRI ICD/CRT-D Post Approval Study
BiotronikBioMonitor 2
Rhythm PharmaceuticalsFull Automaticity and Remote Follow-up
Rhythm PharmaceuticalsActivation of preventive and therapeutic algorithms for treatment of AF

Clinical Trials (9)

Total enrollment: 26,527 patients across 9 trials

NCT00324662BiotronikImplantable cardioverter-defibrillator

Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)

Start: Aug 2003Est. completion: Jul 2008260 patients
Phase 4Completed
NCT07360158BiotronikCorSky ICD or CRT-D

BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs

Start: Jun 2026Est. completion: May 2028151 patients
N/ANot Yet Recruiting
NCT06382207Eko DevicesEko Duo electronic stethoscope

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Start: Jan 2025Est. completion: Jul 2026100 patients
N/ARecruiting
NCT04863664Rhythm PharmaceuticalsDefibrillation

Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

Start: Jun 2021Est. completion: Nov 2025998 patients
N/ACompleted
NCT04025710BiotronikBIOMONITOR III and BIOMONITOR IIIm

Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep)

Start: Oct 2019Est. completion: Apr 2022167 patients
N/ACompleted
NCT02933619BiotronikProMRI ICD/CRT-D Post Approval Study

ProMRI ICD/CRT-D Post Approval Study

Start: Aug 2016Est. completion: Apr 201924,249 patients
N/ACompleted
NCT02565238BiotronikBioMonitor 2

BIO.MASTER.BioMonitor 2 Study

Start: Sep 2015Est. completion: Feb 201792 patients
N/ACompleted
NCT01526629Rhythm PharmaceuticalsFull Automaticity and Remote Follow-up

Full Automaticity and Remote Follow-up

Start: May 2011Est. completion: Mar 2015354 patients
N/ACompleted
NCT00170274Rhythm PharmaceuticalsActivation of preventive and therapeutic algorithms for treatment of AF

APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias

Start: Aug 2000Est. completion: Oct 2014156 patients
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr

Physician Program Director, Los Angeles

Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr

J&J MedTech Neurovascular Senior Financial Analyst, R&D

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$79K - $128K/yr

Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90

Johnson & Johnson
Issy-les-Moulineaux, France
Yesterday

Trainee Technical Specialist

Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 26,527 patients
3 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)